Diagnostic Services
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 581.25 | 535.09 | 618.11 | 507.05 | 440.93 |
Total Expenses | 485.66 | 447.68 | 390.21 | 354.51 | 294.45 |
Profit Before Tax | 95.98 | 88.59 | 227.72 | 152.47 | 140.41 |
Profit After Tax | 69.49 | 64.36 | 176.14 | 113.15 | 88.40 |
Operating Profit after Depreciation | 99.79 | 89.76 | 230.27 | 153.41 | 148.33 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 305.88 | 293.89 | 284.95 | 253.06 | 269.09 |
Total Non Current Assets | 365.37 | 359.78 | 337.64 | 305.36 | 318.89 |
Total Current Assets | 278.51 | 272.94 | 270.02 | 240.44 | 151.99 |
TOTAL ASSETS | 643.88 | 632.72 | 607.66 | 545.80 | 470.88 |
Total Shareholder's Fund | 526.77 | 534.30 | 526.57 | 427.28 | 366.65 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 167.62 | 129.31 | 113.41 | 114.73 | 167.88 |
Net Cash used in Investing Activities | -91.28 | -38.99 | -23.57 | -48.66 | 0.95 |
Net Cash used in Financing Activities | -84.81 | -86.18 | -89.41 | -61.58 | -164.78 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 531.20 | 491.85 | 568.93 | 486.55 | 410.48 |
Total Expenses | 432.98 | 410.78 | 361.55 | 325.27 | 254.15 |
Profit Before Tax | 98.22 | 81.07 | 207.38 | 161.28 | 112 |
Profit After Tax | 71.14 | 56.97 | 152.05 | 119.77 | 79.32 |
Operating Profit after Depreciation | 101.95 | 83.32 | 209.76 | 161.94 | 157.65 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 158.29 | 155.63 | 148.31 | 118.03 | 110.39 |
Total Non Current Assets | 374.62 | 376.50 | 366.15 | 345.29 | 328.74 |
Total Current Assets | 245.65 | 235.37 | 231.02 | 182.50 | 113.65 |
TOTAL ASSETS | 620.27 | 611.87 | 597.17 | 527.79 | 442.39 |
Total Shareholder's Fund | 513.81 | 521.04 | 520.70 | 445.46 | 378.23 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 155.19 | 120.02 | 105.68 | 111.07 | 136.33 |
Net Cash used in Investing Activities | -80.29 | -31.65 | -12.32 | -53.09 | 26.84 |
Net Cash used in Financing Activities | -83.71 | -87.50 | -86.91 | -57.81 | -162.65 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 177.36 | 156.91 | 154.25 | 134.74 | 148 |
Total Expenses | 129.36 | 114.62 | 120.66 | 103.15 | 110.48 |
Profit Before Tax | 36.78 | 33.55 | 22.90 | 19.91 | 28.27 |
Profit After Tax | 26.42 | 23.94 | 17.18 | 14.74 | 20.33 |
Operating Profit after Depreciation | 50.61 | 45.90 | 37.08 | 34.45 | 40.05 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 163.05 | 143.63 | 141.23 | 122.89 | 136.29 |
Total Expenses | 114.26 | 101.28 | 107.64 | 92.36 | 99.66 |
Profit Before Tax | 40.34 | 35.14 | 25.05 | 20.76 | 28.13 |
Profit After Tax | 29.59 | 25.15 | 19.23 | 14.89 | 20.29 |
Operating Profit after Depreciation | 50.91 | 45.52 | 36.40 | 32.62 | 38.45 |
₹18/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Thyrocare Technologies Ltd | ₹821.45 | ₹4,353.01 |
Max Healthcare Institute Ltd | ₹1,078.10 | ₹1,04,805.56 |
Apollo Hospitals Enterprise Ltd | ₹6,918.65 | ₹99,479.57 |
Fortis Healthcare Ltd | ₹639.80 | ₹48,302.22 |
Syngene International Ltd | ₹832.10 | ₹33,495.10 |
Global Health Ltd | ₹1,055.75 | ₹28,356.11 |
17 Jan 2025, 02:21 pm
07 Jan 2025, 02:45 pm
24 Oct 2024, 11:15 am
17 Oct 2024, 01:42 pm
19 Sep 2024, 02:29 pm